Introduction Generic Drug Development for Poorly Soluble APIs requires advanced Contract Development and Manufacturing Organization (CDMO) strategies to address the … Continue reading Generic Drug Development for Poorly Soluble APIs: CDMO Approaches Using ASD, Nano, and Lipid Systems